Moreover, we found that high expression of ALKBH5 and/or TIRAP was significantly associated with the poor overall survival of glioblastoma and thyroid cancer patients receiving radiotherapy from TCGA database(Figure 7D–E), suggesting ALKBH5 and TIRAP have prognostic value for certain patients receiving radiotherapy. Here, ALKBH5 is linked to thyroid gland carcinoma.